Whalegun
Home

Jonathan Zalevsky, Chief R&D Officer: Nektar Therapeutics NKTR Planned sale · Filed 25/11/25

Trade details

Type
Planned sale notice
Stock
Nektar Therapeutics NKTR
Person
Jonathan ZalevskyChief R&D Officer
Planned sale date
25/11/25
Filed
25/11/25

More to sell after $72.3K in 3 months

Nektar Therapeutics trades, last 26 weeks

What else happened in Nektar Therapeutics around then

Filed or reported within 30 days of the trade day · 25/10/26~25/12/25

Jonathan Zalevsky's recent trades

  • Jonathan Zalevsky

    Planned saleNektar Therapeutics

    $13.4K

    Filed 08/18

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $371.5K

    Filed 06/30

  • Jonathan Zalevsky

    Sell10b5-1 planNektar Therapeutics

    $336.2K

    Filed 06/17

  • Jonathan Zalevsky

    Planned sale10b5-1 planNektar Therapeutics

    $328.8K

    Filed 06/15

  • Jonathan Zalevsky

    SellNektar Therapeutics

    $13K

    Filed 05/21

Jonathan Zalevsky, Chief Officer — plans to sell 1,157 sh of Nektar Therapeutics NKTR · $68.1K · around 11/25 | Whalegun